News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

HemCon Medical Technologies, Inc. and Zeria Pharmaceutical Co., Ltd. Sign Exclusive Licensing Agreement for HemCon’s Innovative Product Line in Japan



4/9/2010 8:57:15 AM

PORTLAND, Ore.--(BUSINESS WIRE)--HemCon Medical Technologies, Inc. (“HemCon”), an innovative developer of advanced medical products, is proud to announce the signing of an exclusive licensing agreement with Zeria Pharmaceuticals Co. Ltd. (“Zeria”), a leading pharmaceutical and consumer healthcare products company. Through this partnership, Zeria will market, distribute, and sell HemCon’s line of revolutionary wound and oral care dressings throughout Japan.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES